Artificial intelligence is poised to revolutionize healthcare, becoming one of its most crucial applications. 

In this episode, Kimberly Powell, the vice president of NVIDIA’s healthcare department, discusses how AI is transforming healthcare from drug discovery to surgical procedures. She highlights the ability of AI to represent drugs in computers, accelerating drug development and clinical trials, with some AI-designed drugs already in clinical trials. Kim explains how generative AI can enhance surgical outcomes through digital agents that aid in pre-op preparation, provide real-time surgical guidance, and automate post-op documentation. She notes how AI can help to provide healthcare access globally by codifying medical expertise and powering cost-effective, miniaturized devices. Kim also touches upon the importance of guardrails for privacy, security, and bias in AI systems, including embedding AI models directly into medical devices. 

Tune in and learn how AI is reshaping the future of healthcare as a digital employee!

Resources:

Connect with and follow Kimberly Powell on LinkedIn.

Discover more about NVIDIA on their LinkedIn and website.